Inhibitors of the 26s proteolytic complex and the 20s proteasome

Details Inhibitors of the 26s proteolytic complex and the 20s proteasome Inhibitors of the 26s proteolytic complex and the 20s proteasome

1995-01-15

1997-12-02

Johnson, Jerry D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 19, 530331, 560 20, 560 27, 560 31, 560 32, 560 41, 560 47, 560159, A61K 3800, C07K 500, C07C27100, C07C22900

Patent

active

056936176

ABSTRACT:
Disclosed herein is a method for reducing the rate of degradation of proteins in an animal comprising contacting cells of the animal with certain proteasome inhibitors. The structure of the inhibitors are also disclosed.

REFERENCES:
patent: 4261868 (1981-04-01), Hora et al.
patent: 4369183 (1983-01-01), Jones et al.
patent: 4499082 (1985-02-01), Shenvi et al.
patent: 4510130 (1985-04-01), Platt et al.
patent: 4525309 (1985-06-01), Matteson et al.
patent: 4537707 (1985-08-01), Severson, Jr.
patent: 4537773 (1985-08-01), Shenvi
patent: 4842769 (1989-06-01), Shulman et al.
patent: 4963655 (1990-10-01), Kinder et al.
patent: 4997929 (1991-03-01), Collins et al.
patent: 5030378 (1991-07-01), Venegas
patent: 5106948 (1992-04-01), Kinder et al.
patent: 5169841 (1992-12-01), Kleeman et al.
patent: 5187157 (1993-02-01), Kettner et al.
patent: 5242904 (1993-09-01), Kettner et al.
patent: 5250720 (1993-10-01), Kettner et al.
patent: 5340736 (1994-08-01), Goldberg et al.
Angelastro et al., ".alpha.-Diketone and .alpha.-Keto Ester Derivatives of N-Protected Amino Acids and Peptides as Novel Inhibitors of Cysteine and Serine Proteinases," J. Med. Chem. 33(1):11-13 (1990).
Angliker et al., "The Synthesis of Lysylfluoromethanes and Their Properties as Inhibitors of Trypsin, Plasmin and Cathepsin B," Biochem. J. 241:871-875 (1987).
Aoyagi et al., "Structures and Activities of Protease Inhibitors of Microbial Origin," in: Proteases and Biological Control, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp. 429-454 (1975).
Bachmair et al., "In Vivo Half-Life of a Protein Is a Function of Its Amino-Terminal Residue," Science 234:179-186 (1986).
Badalamente et al., "Neuromuscular Recovery Using Calcium Protease Inhibition After Median Nerve Repair in Primates," Proc. Natl. Acad. Sci. USA 86:5983-5987 (1989).
Boches et al., "Role for the Adenosine Triphosphate-Dependent Proteolytic Pathway in Reticulocyte Maturation," Science 215:978-980 (1982).
Brown, H.C., and Gupta, S.K., "The Facile Redistribution of Trialkylboranes with Trimethylene Borate. A Simple, General Synthesis of Alkaneboronic Esters and Acids from Olefins via Hydroboration," J. Am. Chem. Soc. 92:6983-6984 (1970).
Brown, H.C., and Gupta, S.K., "1,3,2-Benzodioxaborole, a Convenient Monofunctional Hydroborating Agent. A Simple New Synthesis of Alkaneboronic Esters and Acids from Olefins via Hydroboration," J. Am. Chem. Soc. 93:1816-1818 (1971).
Brown et al., "Structural and Serological Similarity of MHC-linked LMP and Proteasome (Multicatalytic Proteinase) Complexes," Nature 353:355-357 (1991).
Carbone et al., "Class I-Restricted Processing and Presentation of Exogenous Cell-Associated Antigen In Vivo," J. Exp. Med. 171:377-387 (1990).
Ciechanover et al., "Ubiquitin Dependence of Selective Protein Degradation Demonstrated in the Mammalian Cell Cycle Mutant ts85," Cell 37(1):57-66 (1984).
Dick et al., "Degradation of Oxidized Insulin B Chain by the Multiproteinase Complex Macropain (Proteasome)," Biochemistry 30:2725-2734 (1991).
Donehower et al., "Mice Deficient for p53 are Developmentally Normal but Susceptible to Spontaneous Tumours," Nature 356:215-221 (1992).
Driscoll et al., "A Controlled Breakdown: Antigen Processing and the Turnover of Viral Proteins," Cell 68:823-825 (1992).
Driscoll et al., "The Proteasome (Multicatalytic Protease) Is a Component of the 1500-kDa Proteolytic Complex Which Degrades Ubiquitin-Conjugated Proteins," J. Biol. Chem. 265(9):4789-4792 (1990).
Dubiel et al., "Purification of a 11S Regulator of the Multicatalytic Protease," J. Biol. Chem. 267(31):22369-22377 (1992).
Ewoldt et al., "Sulfonyl Fluoride Serine Protease Inhibitors Inactivate RNK-16 Lymphocyte Granule Proteases and Reduce Lysis by Granule Extracts and Perforin," Molec. Immunol. 29(6):713-721 (1992).
Eytan et al., "ATP-dependent Incorporation of 20S Protease into the 26S Complex That Degrades Proteins Conjugated to Ubiquitin," Proc. Natl. Acad. Sci. USA 86:7751-7755 (1989).
Fehrentz et al., "An Efficient Synthesis of Optically Active .alpha.-(t-Butoxycarbonylamino)-aldehydes From .alpha.-Amino Acids," Synthesis, pp.676-678 (1983).
Fehrentz et al., "Synthesis of Aldehydic Peptides Inhibiting Renin," Int. J. Peptide Protein Res. 26:236-241 (1985).
Furuno et al., "Role of Different Proteolytic Systems in the Degradation of Muscle Proteins during Denervation Atrophy," J. Biol. Chem. 265(15):8550-8557 (1990).
Ganoth et al., "A Multicomponent System That Degrades Proteins Conjugated to Ubiquitin," J. Biol. Chem. 263 (25):12412-12419 (1988).
Glynne et al., "A Proteasome-Related Gene Between the Two ABC Transporter Loci in the Class II Region of the Human MHC," Nature 353:357-360 (1991).
Goldberg, A.L., "The Mechanism and Functions of ATP-dependent Proteases in Bacterial and Animal Cells," Eur. J. Biochem. 203:9-23 (1992).
Goldberg et al., "Proteolysis, Proteasomes and Antigen Presentation," Nature 357:375-379 (1992).
Gonda et al., "Universality and Structure of the N-end Rule," J. Biol. Chem. 264(28):16700-16712 (1989).
Green et al., "Peptidyl Diazomethyl Ketones Are Specific Inactivators of Thiol Proteinases," J. Biol. Chem. 256(4):1923-1928 (1981).
Gronostajski et al., "The ATP Dependence of the Degradation of Short- and Long-Lived Proteins in Growing Fibroblasts," J. Biol Chem. 260(6):3344-3349 (1985).
Hall et al., "High Levels of p53 Protein in UV-irradiated Normal Human Skin," Oncogene 8:203-207 (1993).
Hanada et al., "Characterization of the Three New Analogs of E-64 and Their Therapeutic Application," in: Proteinase Inhibitors: Medical and Biological Aspects, Katunuma et al. (eds.), New York: Springer-Verlag Publishers, pp. 25-36 (1983).
Hayashi et al., "Activation of Intracellular Calcium-Activated Neutral Proteinase in Erythrocytes and Its Inhibition by Exogenously Added Inhibitors," Biochim. Biophys. Acta 1094:249-256 (1991).
Hernandez et al., "Effect of the 7-Amino Substituent on the Inhibitory Potency of Mechanism-Based Isocoumarin Inhibitors for Porcine Pancreatic and Human Neutrophil Elastases," J. Med. Chem. 35:1121-1129 (1992).
Hershko et al., "The Ubiquitin System For Protein Degradation," Annu. Rev. Biochem. 61:761-807 (1992).
Hiwasa et al., "Cysteine Proteinase Inhibitors and Ras Gene Products Share the Same Biological Activities Including Transforming Activity Toward NIH3T3 Mouse Fibroblasts and the Differentiation-Inducing Activity Toward PC12 Rat Pheochromocytoma Cells," Carcinogenesis 11(1):75-80 (1990).
Hough et al., "Purification of Two High Molecular Weight Proteases from Rabbit Reticulocyte Lysate," J. Biol. Chem. 262(17):8303-8313 (1987).
Hudig et al., "The Function of Lymphocyte Proteases," J. Immunol. 147(4):1360-1368 (1991).
Hudig et al., "Selective Isocoumarin Serine Protease Inhibitors Block RNK-16 Lymphocyte Granule-Mediated Cytolysis," Molec. Immunol. 26(8):793-798 (1989).
Inoue et al., "Inhibition of Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase in Vivo by Cysteine Protease Inhibitors," J. Biol. Chem. 266(20):13311-13317 (1991).
Ito et al., "The Synthesis and Properties of Tripeptide Aldehydes Having Neurite-Extension Activity," Chem. Abstr. 118:885, Abstract No. 148014h (1992).
Kajiwara et al., "Elucidation of Calpain Dependent Phosphorylation of Myosin Light Chain Human Platelets," Biochemi. Int. 15 (5):935-944 (1987).
Kam et al., "Mechanism-Based Isocoumarin Inhibitors for Trypsin and Blood Coagulation Serine Proteases: New Anticoagulants," Biochemistry 27:2547-2557 (1988).
Kam et al., "Thioester Chromogenic Substrates for Human Factor VIIa: Substituted Isocoumarins Are Inhibitors of Factor VIIa and In Vitro Anticoagulants," Thrombosis and Haemostasis 64 (1):133-137 (1990).
Kastan et al., "A Mammalian Cell Cycle Checkpoint Pathway Utilizing p53 and GADD45 Is Defective in Ataxia-Telangiectasia," Cell 71:587-597 (1992).
Kastan et al., "Participation of p53 Protein in the Cellular Response to DNA Damage," Cancer Res. 51:6304-6311 (1991).
Kelly et al., "Second Proteasome-Related Gene in the Human MHC class II Region," Nature 353:667-668 (1991).
Kennedy et al., "Mechanism of Association of

Affiliated with

Also associated with

Rating

Inhibitors of the 26s proteolytic complex and the 20s proteasome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of the 26s proteolytic complex and the 20s proteasome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of the 26s proteolytic complex and the 20s proteasome will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-801317